ICU Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1994
Net Income	-29.66	-74.29	103.14	86.87	101.04	Upgrade
Depreciation & Amortization	250.68	258.8	99.29	94.85	85.21	Upgrade
Share-Based Compensation	40.56	36.03	27.34	23.95	21.92	Upgrade
Other Operating Activities	-95.39	-282.67	37.77	17.08	-106.25	Upgrade
Operating Cash Flow	166.2	-62.13	267.54	222.75	101.92	Upgrade
Operating Cash Flow Growth	-	-	20.11%	118.56%	-36.39%	Upgrade
Capital Expenditures	-92.17	-98.34	-80.95	-94.21	-106.01	Upgrade
Acquisitions	0	-1,844.16	-14.45	0	-76.13	Upgrade
Change in Investments	4.22	33.04	4.72	-3.93	15.25	Upgrade
Investing Cash Flow	-87.95	-1,909.47	-90.69	-98.14	-166.89	Upgrade
Share Issuance / Repurchase	4.02	8.79	9.37	13.19	7.73	Upgrade
Debt Issued / Paid	-30.65	1,639	-0.61	-0.36	0	Upgrade
Other Financing Activities	-9.35	-10.88	-25.64	-12.88	-18.64	Upgrade
Financing Cash Flow	-35.98	1,637	-16.87	-0.04	-10.91	Upgrade
Exchange Rate Effect	3.16	-9.48	-3.25	2.85	-0.23	Upgrade
Net Cash Flow	45.44	-344.04	156.73	127.43	-76.11	Upgrade
Free Cash Flow	74.03	-160.47	186.59	128.54	-4.09	Upgrade
Free Cash Flow Growth	-	-	45.16%	-	-	Upgrade
Free Cash Flow Margin	3.28%	-7.04%	14.18%	10.11%	-0.32%	Upgrade
Free Cash Flow Per Share	3.07	-6.72	8.80	6.15	-0.20	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).